BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//American Liver Foundation - ECPv6.13.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:American Liver Foundation
X-ORIGINAL-URL:https://liverfoundation.org
X-WR-CALDESC:Events for American Liver Foundation
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220329T000000
DTEND;TZID=America/New_York:20220329T235900
DTSTAMP:20260403T160157
CREATED:20220303T003500Z
LAST-MODIFIED:20220719T152805Z
UID:10000101-1648512000-1648598340@liverfoundation.org
SUMMARY:NIH v. Cleveland Clinic Florida | Yale University v. University of Maryland Medical Center | Children’s Hospital of Harvard v. Brown University
DESCRIPTION:Academic Debates professional education programs provide primary care physicians a unique opportunity to learn more directly from specialists on various topics.  They usually include a presentation followed by a Q & A where participants have the chance to ask questions. Topics are different at every program and may include: liver wellness\, viral hepatitis\, alcohol-related liver disease\, NASH/NAFLD\, cirrhosis\, autoimmune liver diseases\, pediatric conditions\, and diet/nutrition. \nDebate 1\nPatients with decompensated HVC cirrhosis (and HCC?) who are not liver transplant recipients SHOULD be offered HCV treatment? – Patients with decompensated HVC cirrhosis (and HCC?) who are not liver transplant recipients SHOULD NOT be offered HCV treatment?\nNational Institutes of Health v. Cleveland Clinic Florida \nDebate 2\nShould TIPS be places in patients with HRS-AKI?\nYale University v. University of Maryland Medical Center \nDebate 3\nEndoscopic variceal surveillance and primary prophylaxis of esophageal variceal hemorrhage is INDICATED in cirrhotic children. – Endoscopic variceal surveillance and primary prophylaxis of esophageal variceal hemorrhage is BOT INDICATED in cirrhotic children.\nChildren’s Hospital of Harvard v. Brown University \n[otw_shortcode_button href="https://alfevents.org/debatemadness/register29/" size="medium" icon_position="left" shape="radius" color_class="otw-red" target="_blank"]Register to attend[/otw_shortcode_button]
URL:https://alfevents.org/debatemadness/#new_tab
CATEGORIES:Programs
ATTACH;FMTTYPE=image/jpeg:https://liverfoundation.org/wp-content/uploads/2022/06/2022-Academic-Debates-–-Event-Image.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220328T000000
DTEND;TZID=America/New_York:20220328T235900
DTSTAMP:20260403T160157
CREATED:20220303T002500Z
LAST-MODIFIED:20220719T152813Z
UID:10000100-1648425600-1648511940@liverfoundation.org
SUMMARY:USC v. UCSF | Children’s Hospital of LA v. Children’s Hospital of Colorado
DESCRIPTION:Academic Debates professional education programs provide primary care physicians a unique opportunity to learn more directly from specialists on various topics.  They usually include a presentation followed by a Q & A where participants have the chance to ask questions. Topics are different at every program and may include: liver wellness\, viral hepatitis\, alcohol-related liver disease\, NASH/NAFLD\, cirrhosis\, autoimmune liver diseases\, pediatric conditions\, and diet/nutrition. \nDebate 1 \nSteroid-free immunosuppression SHOULD be the goal of the therapy in ALLF AICH patients\nUniversity of South California v. University of California San Francisco\n \nDebate 2\nGastric Bypass SHOULD be the treatment of choice for NALFD with moderate fibrosis in adolescents\nChildren’s Hospital of Los Angeles v. Children’s Hospital of Colorado \n[otw_shortcode_button href="https://alfevents.org/debatemadness/register28/" size="medium" icon_position="left" shape="radius" color_class="otw-red" target="_blank"]Register to Attend[/otw_shortcode_button]
URL:https://alfevents.org/debatemadness/#new_tab
CATEGORIES:Programs
ATTACH;FMTTYPE=image/jpeg:https://liverfoundation.org/wp-content/uploads/2022/06/2022-Academic-Debates-–-Event-Image.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220320T000000
DTEND;TZID=America/New_York:20220320T235900
DTSTAMP:20260403T160157
CREATED:20220119T223800Z
LAST-MODIFIED:20220621T161405Z
UID:10000086-1647734400-1647820740@liverfoundation.org
SUMMARY:ALF Liver Life Challenge: United Airlines NYC Half Marathon
DESCRIPTION:It’s more than a race\, it’s moments that will challenge\, inspire and change you! From the moment you become part of our team to the moment you cross the finish line\, the Liver Life Challenge provides an unforgettable experience.
URL:https://liverlifechallenge.org/nychalfmarathon/#new_tab
CATEGORIES:Events
ATTACH;FMTTYPE=image/jpeg:https://liverfoundation.org/wp-content/uploads/2022/06/New-Brand-LF.org-Challenge-Events-4.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220301T000000
DTEND;TZID=America/New_York:20220330T235900
DTSTAMP:20260403T160157
CREATED:20220119T224900Z
LAST-MODIFIED:20220621T161403Z
UID:10000085-1646092800-1648684740@liverfoundation.org
SUMMARY:ALF Liver Life Challenge: 30 in 30 Challenge
DESCRIPTION:Are you willing to go the extra mile for ALF? Then join us for the 30 in 30 Challenge. \nRun\, Bike\, Hike or Swim 30 miles in 30 days to support the 30 million Americans affected by liver disease.
URL:https://liverlifechallenge.org/30in30/#new_tab
CATEGORIES:Events
ATTACH;FMTTYPE=image/jpeg:https://liverfoundation.org/wp-content/uploads/2022/06/New-Brand-LF.org-Challenge-Events-5.jpg
END:VEVENT
END:VCALENDAR